Latest Insider Transactions at Laboratory Corp Of America Holdings (LH)
This section provides a real-time view of insider transactions for Laboratory Corp Of America Holdings (LH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LABORATORY CORP OF AMERICA HOLDINGS to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LABORATORY CORP OF AMERICA HOLDINGS's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 06
2025
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
743
+11.39%
|
-
|
Feb 06
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-1.61%
|
$18,031
$247.74 P/Share
|
Feb 06
2025
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
223
+4.68%
|
-
|
Feb 06
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
62
-2.18%
|
$15,314
$247.74 P/Share
|
Feb 06
2025
|
Akinbolade Oyegunwa EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
180
+5.95%
|
-
|
Feb 06
2025
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
70
-11.36%
|
$17,290
$247.74 P/Share
|
Feb 06
2025
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
BUY
Exercise of conversion of derivative security
|
Direct |
180
+22.61%
|
-
|
Feb 06
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102
-3.3%
|
$25,194
$247.74 P/Share
|
Feb 06
2025
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
386
+11.11%
|
-
|
Feb 06
2025
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,240
-1.35%
|
$306,280
$247.74 P/Share
|
Feb 06
2025
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,460
+4.63%
|
-
|
Feb 06
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-2.07%
|
$11,362
$247.74 P/Share
|
Feb 06
2025
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
133
+5.65%
|
-
|
Feb 06
2025
|
Anita Z Graham EVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
118
-19.09%
|
$29,146
$247.74 P/Share
|
Feb 06
2025
|
Anita Z Graham EVP, CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
326
+34.53%
|
-
|
Feb 06
2025
|
Julia Aijun Wang Chief Financial Officer, EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
336
-37.63%
|
$82,992
$247.74 P/Share
|
Feb 06
2025
|
Julia Aijun Wang Chief Financial Officer, EVP |
BUY
Exercise of conversion of derivative security
|
Direct |
893
+50.0%
|
-
|
Feb 06
2025
|
Peter M Neupert Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+6.83%
|
-
|
Feb 06
2025
|
Richelle P Parham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+9.06%
|
-
|
Feb 06
2025
|
Kathryn E Wengel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+22.58%
|
-
|
Feb 06
2025
|
Garheng Kong Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+6.85%
|
-
|
Feb 06
2025
|
Jeffrey A. Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+17.14%
|
-
|
Feb 06
2025
|
Kerrii B Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+6.46%
|
-
|
Feb 06
2025
|
Kirsten Marie Kliphouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+29.44%
|
-
|
Feb 06
2025
|
Dwight Gary Gilliland Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+9.83%
|
-
|
Feb 06
2025
|
Paul Rothman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
944
+36.06%
|
-
|
Jan 07
2025
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
1,000
-7.29%
|
$235,000
$235.0 P/Share
|
Dec 02
2024
|
Glenn A Eisenberg Executive Vice President |
SELL
Open market or private sale
|
Direct |
11,711
-27.23%
|
$2,810,640
$240.43 P/Share
|
Dec 02
2024
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,711
+12.12%
|
$2,517,865
$215.46 P/Share
|
Dec 02
2024
|
Dwight Gary Gilliland Director |
SELL
Open market or private sale
|
Direct |
1,000
-11.48%
|
$241,000
$241.0 P/Share
|
Nov 22
2024
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,671
-45.95%
|
$873,698
$238.91 P/Share
|
Nov 22
2024
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,015
+33.44%
|
$674,520
$168.52 P/Share
|
Nov 21
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,000
-27.26%
|
$239,000
$239.42 P/Share
|
Nov 11
2024
|
Adam H Schechter President & CEO |
SELL
Open market or private sale
|
Direct |
6,189
-6.61%
|
$1,503,927
$243.47 P/Share
|
Oct 24
2024
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
1,000
-6.79%
|
$230,000
$230.0 P/Share
|
Aug 19
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-35.28%
|
$454,000
$227.05 P/Share
|
Aug 15
2024
|
Glenn A Eisenberg Executive Vice President |
SELL
Open market or private sale
|
Direct |
15,000
-11.91%
|
$3,345,000
$223.61 P/Share
|
Aug 08
2024
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
586
-3.83%
|
$131,850
$225.0 P/Share
|
Aug 07
2024
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
414
-2.63%
|
$93,150
$225.0 P/Share
|
Aug 05
2024
|
Lance Berberian EVP, Special Advisor, Strategy |
SELL
Open market or private sale
|
Direct |
12,093
-23.12%
|
$2,769,297
$229.36 P/Share
|
Jun 06
2024
|
Paul Rothman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
717
+50.0%
|
-
|
May 14
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-13.5%
|
$420,000
$210.83 P/Share
|
May 02
2024
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
250
-1.57%
|
$50,000
$200.1 P/Share
|
Apr 30
2024
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
250
-1.54%
|
$51,000
$204.13 P/Share
|
Apr 30
2024
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,496
-8.85%
|
$903,696
$201.37 P/Share
|
Apr 30
2024
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,229
+16.77%
|
-
|
Apr 29
2024
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,439
-53.89%
|
$497,556
$204.33 P/Share
|
Apr 15
2024
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,496
-9.98%
|
$912,688
$203.32 P/Share
|
Apr 15
2024
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,229
+18.5%
|
-
|
Apr 01
2024
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Open market or private sale
|
Direct |
6,477
-56.26%
|
$1,405,509
$217.29 P/Share
|